Management of Acute Asthma Exacerbation
Immediately administer high-flow oxygen (40-60%) to maintain SaO₂ >90%, nebulized albuterol 5 mg (or 4-8 puffs via MDI with spacer), and systemic corticosteroids (prednisolone 30-60 mg orally or IV hydrocortisone 200 mg) within the first 15-30 minutes—these three interventions form the cornerstone of acute asthma management and must not be delayed. 1, 2
Initial Assessment and Severity Recognition
Assess severity objectively within 15-30 minutes using peak expiratory flow (PEF) or FEV₁, as underestimation due to inadequate objective measurements is the most common preventable cause of asthma deaths. 3, 1
Severe Exacerbation Features:
- Inability to complete sentences in one breath 3
- Respiratory rate >25 breaths/min 3
- Heart rate >110 beats/min 3
- PEF <50% of predicted or personal best 3
Life-Threatening Features Requiring Immediate ICU Consideration:
- PEF <33% of predicted or personal best 3, 1
- Silent chest, cyanosis, or feeble respiratory effort 3, 1
- Bradycardia or hypotension 3, 1
- Exhaustion, confusion, or coma 3, 1
- Normal or elevated PaCO₂ (≥42 mmHg) in a breathless patient 3, 1
- Severe hypoxia: PaO₂ <8 kPa irrespective of oxygen treatment 3
Immediate Treatment Protocol (First Hour)
Oxygen Therapy:
- Administer 40-60% oxygen via face mask or nasal cannula 3
- Target SaO₂ >90% (>95% in pregnant patients or those with cardiac disease) 1, 2
Bronchodilator Therapy:
- Nebulized albuterol 5 mg or terbutaline 10 mg every 20 minutes for 3 doses 3, 1
- Alternative: 4-8 puffs via MDI with spacer every 20 minutes for 3 doses 1, 2
- For children <15 kg: use half doses (2.5 mg salbutamol) 3
Systemic Corticosteroids (Must Be Given Immediately):
- Adults: Prednisolone 30-60 mg orally OR IV hydrocortisone 200 mg 3
- Children: Prednisolone 1-2 mg/kg (maximum 40 mg) 3
- Oral administration is as effective as IV and is preferred unless the patient cannot tolerate oral intake 2
- Clinical benefits require 6-12 hours minimum to manifest 1
Add Ipratropium Bromide for All Moderate-to-Severe Exacerbations:
- 0.5 mg via nebulizer or 8 puffs via MDI every 20 minutes for 3 doses, then as needed 1, 2
- This combination reduces hospitalizations, particularly in patients with severe airflow obstruction 1, 2
Reassessment at 15-30 Minutes After Initial Treatment
Measure PEF or FEV₁ and evaluate symptoms and vital signs to guide further management. 1, 2
Good Response (PEF >75% predicted):
- Step up usual maintenance treatment 3
- Continue monitoring with PEF chart 3
- Arrange follow-up within 48 hours 3
Incomplete Response (PEF 50-75% predicted):
- Give prednisolone 30-60 mg if not already administered 3
- Continue nebulized beta-agonist every 4-6 hours 3
- Consider hospital admission if more than one severe feature persists 3
Poor Response (PEF <50% predicted or severe features persist):
- Continue oxygen and increase nebulized beta-agonist frequency to every 15-30 minutes 3
- Repeat ipratropium 0.5 mg every 20 minutes for additional doses 3
- Arrange immediate hospital admission 3
Adjunctive Therapies for Severe/Refractory Cases
Intravenous Magnesium Sulfate:
- Indicated for severe exacerbations with PEF <40% after initial treatment or life-threatening features 1, 2
- Dose: 2 g IV over 20 minutes for adults; 25-75 mg/kg (maximum 2 g) for children 1, 2
- Significantly increases lung function and decreases hospitalization necessity 1
Intravenous Aminophylline or Beta-Agonists:
- Consider IV aminophylline 250 mg over 20 minutes OR IV salbutamol/terbutaline 250 µg over 10 minutes for life-threatening features 3
- Do NOT give bolus aminophylline to patients already taking oral theophyllines 3, 4
- Note: Most studies show aminophylline adds little benefit and increases adverse effects; reserve for truly refractory cases 4
Critical Pitfalls to Avoid
- Never administer sedatives of any kind to patients with acute asthma—this is absolutely contraindicated 3, 1
- Do not delay corticosteroid administration while "trying bronchodilators first"—steroids must be given immediately 1, 2
- Do not underestimate severity—always measure PEF or FEV₁ objectively, as subjective assessments are frequently inaccurate 3, 1
- Avoid methylxanthines (theophylline) due to increased side effects without superior efficacy over standard therapy 1, 4
- Do not give bolus aminophylline to patients on oral theophyllines 3, 4
Hospital Admission Criteria
Immediate hospital admission is required for: 3, 1
- Any life-threatening features present
- Features of severe attack persisting after initial treatment
- PEF <33% predicted after treatment
- PEF <50% predicted after 1-2 hours of intensive treatment
Lower threshold for admission if: 3
- Presentation in afternoon or evening rather than morning
- Recent nocturnal symptoms or worsening symptoms
- Previous severe attacks, especially requiring intubation or ICU admission
- Recent hospitalization or ED visit within past month
- Poor social circumstances or inability to assess symptom severity
ICU Transfer Criteria
Transfer to ICU accompanied by a physician prepared to intubate if: 3, 1
- Deteriorating PEF or worsening exhaustion
- Feeble respirations or persistent/worsening hypoxia
- PaCO₂ ≥42 mmHg or rising
- Confusion, drowsiness, or altered mental status
- Coma or respiratory arrest
Discharge Criteria (After Stabilization)
Patients may be discharged when: 1, 2
- PEF ≥70% of predicted or personal best
- Symptoms are minimal or absent
- Oxygen saturation is stable on room air
- Patient is stable for 30-60 minutes after last bronchodilator dose
- Continue oral corticosteroids for 5-10 days (no taper needed for courses <10 days) 1, 2
- Initiate or continue inhaled corticosteroids 1, 2
- Inhaler technique verified and recorded 3
- Provide written asthma action plan 1, 2
- Arrange GP follow-up within 1 week 3
- Arrange specialist follow-up within 4 weeks 3